Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...
Streetwise Reports | May 21, 2020 |

Buzz on the Bullboards: Investment Opportunities on the Rise

(Image via Datametrex AI Ltd.) A busy week for the markets means a busy week for the Stockhouse Bullboards. From sudden investment opportunities to new sector mainstays, we saw a little bit of everything over the last seven days. First up, here&CloseCurlyQuo...
Stockhouse.com | April 20, 2022 |

The Next Big Mover In The Junior Oil Space

(Click to read the report.) Analysts at Beacon Securities Ltd. initiated coverage of Saturn Oil & Gas Inc. ( TSX-V: Soil , Forum ) with a BUY recommendation and a 12-month price target of $10.15. Click HERE or the image above to read the report in f...
Featured Submission | October 28, 2021 |

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...
Dave Jackson | February 13, 2020 |

Crossing the Rubicon into the Super Premium Cannabis Space

Rubicon Organics Inc. ( CSE: ROMJ , OTCQX: ROMJF , Forum ) is a licensed cannabis producer focused on cultivating and branding certified organic, super-premium cannabis. Rubicon trades on the Canadian Securities Exchange under the symbol ROMJ. In this fascina...
Dave Jackson | April 3, 2020 |

No Rules, No Game, No Spectators

There are times in my life where I am forced to fight the urge to do harm to people, something that I have never enjoyed, even when I was playing hockey in the violent Southern Hockey League in 1977. I have taken spears to the groin, butt-ends to the face, hooks to...
Streetwise Reports | March 10, 2020 |

The growing weaponization of space

In his recent State of the Union address, President Trump gave a shout-out to space exploration, highlighting the newly-created Space Force branch of the US Military, and NASA’s Artemis program of crewed lunar exploration. Artemis aims to put astronauts on ...
Richard (Rick) Mills | February 14, 2020 |

The Golden Asteroid That Could Make Everyone On Earth A Billionaire

Whether it was the Big Bang, Midas or God himself, we don't really need to unlock the mystery of the origins of gold when we've already identified an asteroid worth $700 quintillion in precious heavy metals. If anything launches this metals mining space race, it will be th...
Joao Peixe | June 26, 2019 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

dynaCERT, NEL ASA, Royal Helium - benefit from the UN climate mission

Helium and hydrogen are now not only driving space travel and modern mobility, the inert gases are also the focus of investors and politicians. While Elon Musk and Richard Branson want to make space tourism possible and NASA is using SpaceX to implement extensive programmes wi...
Mario Hose | August 13, 2020 |
1 2 3 4 5 6 7 8 9 10 ...